EDGAR Filing Documents for 0000000000-17-017216

Form UPLOAD - SEC-generated letter:

SEC Accession No. 0000000000-17-017216

Filing Date

2017-05-16

Accepted

2017-05-16 16:43:53

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.pdf	LETTER	100526
	Complete submission text file	0000000000-17-017216.txt		139262

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406

Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 6108166640

Nabriva Therapeutics Plc (Filed for) CIK: 0001703287 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations